Management in the febrile, neutropenic patient with cancer: therapeutic considerations (Q39820720)

14 September 2017

1 reference

title

Management in the febrile, neutropenic patient with cancer: therapeutic considerations (English)

1 reference

14 September 2017

Brown AE

1

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 June 1985

1 reference

The Journal of Pediatrics

14 September 2017

published in

1 reference

14 September 2017

volume

106

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

1035-1042

1 reference

CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Neutropenia, fever, and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Approaching the controversies in antibacterial management of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Infectious complications in the child with cancer. II. Management of specific infectious organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Infectious complications in the child with cancer. III. Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Improved prognosis for granulocytopenic patients with gram-negative bacteremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

In vitro antagonism of beta-lactam antibiotics by cefoxitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Postantibiotic effect of imipenem on Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the Future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2885%2980265-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(85)80265-1

1 reference

14 September 2017

1 reference